(TEA) ( Figure 1B) . TEA was added in these experiments prior application of CNQX (20 M, n ϭ 6; Figures 2B and 3). In contrast, application of 20 M CNQX after in order to facilitate calcium spikes so that I sAHP could be evoked reliably. The kainate inhibition of I sAHP observed in kainate did not relieve I sAHP inhibition (n ϭ 3; Figure 2C ). Therefore, the prolonged action is unlikely to be due to the presence of TTX was indistinguishable from controls (35% Ϯ 3% in eight cells; Figure 1C ). persistent receptor activation or slow washout of the kainate but may, instead, reflect the action of an intracelIt has been shown that kainate can increase spontaneous GABA release from CA1 interneurons (Cossart et al., lular messenger. The effect of kainate on I sAHP was concentration dependent, reaching a plateau of 34% at 100 1998). In order to test whether the effect of kainate on I sAHP depended on any secondary activation of receptors nM with an IC 50 ϭ 15 nM ( Figure 2D ). A more complete block was observed with high concentrations of kainate other than the kainate subtype, we used a cocktail of antagonists. Blockers were used for the NMDAR (100 M (84% at 10 M), which were associated with large inward currents. We have restricted our analysis to concentra-DL-AP5), AMPAR (100 M GYKI52466), mGluR (1 mM MCPG and 250 M MSOP), GABA A R (100 M picrotoxin), tions that were not associated with clear ionotropic effects. GABA B R (200 M 2-OH-saclofen), muscarinic AchR (1 M atropine sulfate), opioid (10 M naloxone), cannaIn order to identify the receptor subtype responsible for kainate-induced inhibition of I sAHP , we tested the efbinoid CB 1 (2 M AM 251), and adenosine receptors (0.1 M DPCPX). Under these conditions, a 5 min kainate fects of different AMPA and kainate receptor agonists and antagonists. Figure 3 shows a summary histogram application inhibited the peak amplitude of I sAHP (32% Ϯ 5%, n ϭ 5; Figure 1D ) with a time course similar to that for these effects. Domoate (200 nM), which is a more potent agonist of kainate receptors than kainate itself recorded in control experiments (n ϭ 7; Figure 2A) .
The effect of kainate showed a requirement for AMPA/ (Debonnel et al., 1989), also caused substantial inhibition of I sAHP (51% Ϯ 6% versus 34% Ϯ 6%, respectively). kainate receptors, since it was completely abolished by Figure  5B shows the time course of the calcium spike area for of this action. This was tested in two ways, first by examining the effect of kainate on Ca 2ϩ action potenthe data in Figure 5A ; the average data (inset, Figure  5B ) from eight experiments shows that there was no tials. In current-clamp experiments in the presence of 1 M TTX and 5 mM TEA, depolarizing current injection change in calcium spike area (Ϫ5% Ϯ 3%) 10 min after Stocker et al., 1999) and is distinct from the current underlying the sAHP. In these experiments, the mAHP was studied in isolation following block of I sAHP by inclusion of 100 M 8Br-cAMP in the electrode. The mAHP current was subject to a gentle rundown; however, this was unaffected by a 10 min application of 200 nM kainate (n ϭ 5, Figure 5C ). This evidence suggests that inhibition of voltage-dependent Ca 2ϩ channels is not responsible for the kainate-induced reduction of I sAHP .
Finally, we resolved the consequences of kainate action on excitability by studying the increase in action potential firing caused by 200 nM kainate. Spike frequency is the product of a number of factors including persistent Na current and M current in addition to I sAHP , so the slight drift after kainate application may result from altered balance between other ionic currents. at CA3-CA1 synapses in the hippocampus via a direct presynaptic action. J. Neurosci. 21, 2958-2966.
